These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22515080)

  • 1. Amphotericin B microemulsion reduces toxicity and maintains the efficacy as an antifungal product.
    Damasceno BP; Dominici VA; Urbano IA; Silva JA; Araújo IB; Santos-Magalhães NS; Silva AK; Medeiros AC; Oliveira AG; Egito ES
    J Biomed Nanotechnol; 2012 Apr; 8(2):290-300. PubMed ID: 22515080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Characterization of a Microemulsion System Containing Amphotericin B with Potential Ocular Applications.
    da Silveira WL; Damasceno BP; Ferreira LF; Ribeiro IL; Silva KS; Silva AL; Giannini MJ; da Silva-Júnior AA; de Oliveira AG; do Egito ES
    Curr Drug Deliv; 2016; 13(6):982-93. PubMed ID: 26549650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
    Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
    Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the freeze-drying process on the physicochemical and biological properties of pre-heated amphotericin B micellar systems.
    Siqueira SD; Silva-Filho MA; Silva CA; Araújo IB; Silva AE; Fernandes-Pedrosa MF; Oliveira AG; Egito ES
    AAPS PharmSciTech; 2014 Jun; 15(3):612-9. PubMed ID: 24510525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of microemulsion based delivery system for amphotericin B.
    Darole PS; Hegde DD; Nair HA
    AAPS PharmSciTech; 2008; 9(1):122-8. PubMed ID: 18446472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
    Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
    Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
    Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
    Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC).
    Ling JTS; Roberts CJ; Billa N
    AAPS PharmSciTech; 2019 Mar; 20(3):136. PubMed ID: 30838459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting the Jump on the Development of Bullfrog Oil Microemulsions: a Nanocarrier for Amphotericin B Intended for Antifungal Treatment.
    Oliveira WN; Amaral-Machado L; Alencar EN; Marcelino HR; Genre J; Silva-Rocha WP; Gondim AD; Chaves GM; Fernandes-Pedrosa MF; Egito EST
    AAPS PharmSciTech; 2018 Aug; 19(6):2585-2597. PubMed ID: 29916194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity.
    Casa DM; Carraro TC; de Camargo LE; Dalmolin LF; Khalil NM; Mainardes RM
    J Nanosci Nanotechnol; 2015 Jan; 15(1):848-54. PubMed ID: 26328449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.
    Mohamed HA; Radwan RR; Raafat AI; Ali AE
    Drug Deliv Transl Res; 2018 Feb; 8(1):191-203. PubMed ID: 29280061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects.
    Leonhard V; Alasino RV; Munoz A; Beltramo DM
    Curr Drug Deliv; 2018; 15(6):850-859. PubMed ID: 28925873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and toxicity of amphotericin B/triglyceride emulsion formulations.
    Lance MR; Washington C; Davis SS
    J Antimicrob Chemother; 1995 Jul; 36(1):119-28. PubMed ID: 8537259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.